Wockhardt Bio AG reported earnings results for the full year ended March 31, 2022. For the full year, the company reported revenue was USD 329.6 million compared to USD 308.8 million a year ago. Net loss was USD 2.97 million compared to net income of USD 37.29 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to basic earnings per share from continuing operations of USD 0.72 a year ago.